Anti-fibrotic agent assay
CA 2269711 A1 · Owner: Gosiewska, Anna · Inventors: Geesin, Jeffrey C.; Gosiewska, Anna
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel method has been developed for screening anti-scarring and antifibrotic agents. This method offers simplicity it is reproducible and could , be adopted to screen a large number of new potential anti-fibrotic agents. This method has characteristics in common with the BAEC/BASMC co-culture system, but is more sensitive and does not require screening a large number of clonal lines for developing an effective method. In this system similarly to , the co-culture system, activation of L-TGF-.beta.1 occurs by several independent mechanisms which involve binding of the latent complex to M6P/IGF- II receptors, thrombospondin and/or tissue type II transglutaminase. But in , contrast to the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 24, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.